Cargando…

Alteration in the Immune Microenvironment Based on APC Status in MSS/pMMR Colon Cancer

INTRODUCTION: Immunotherapy is currently the most promising antitumor treatment approach. However, the colon cancer immunotherapy indication dMMR/MSI-H do not cover all colon cancer patients suitable for immunotherapy. We performed transcriptome-wide expression profile analyses of pMMR/MSS colon ade...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Haishan, Cao, Bangwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348928/ https://www.ncbi.nlm.nih.gov/pubmed/35937946 http://dx.doi.org/10.1155/2022/3592990

Ejemplares similares

Case report: Bullous pemphigoid associated with sintilimab therapy for pMMR/MSS colorectal cancer
por: Wang, Ting, et al.
Publicado: (2023)

PD-1 inhibitor combined with radiotherapy and GM-CSF in MSS/pMMR metastatic colon cancer: a case report
por: Yang, Jiabao, et al.
Publicado: (2023)

Recurrent Gallbladder Carcinoma With pMMR/MSS Achieved a Complete Response Following Camrelizumab Combined With Apatinib: A Case Report
por: Zhong, Liting, et al.
Publicado: (2022)

Immunotherapy combined with local therapy in the late-line treatment of repair-proficient (pMMR)/microsatellite stable (MSS) metastatic colorectal cancer
por: Ding, Yuwei, et al.
Publicado: (2023)

Squamous cell carcinoma of ascending colon with pMMR/MSS showed a partial response to PD-1 blockade combined with chemotherapy: A case report
por: Liu, Yan, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors in pMMR Metastatic Colorectal Cancer: A Tough Challenge
por: Marmorino, Federica, et al.
Publicado: (2020)

Rectosigmoid-Junction Squamous Cell Carcinoma With pMMR/MSS Achieved a Partial Response Following PD-1 Blockade Combined With Chemotherapy: A Case Report
por: He, Yanxin, et al.
Publicado: (2021)

Successful Treatment of pMMR MSS IVB Colorectal Cancer Using Anti-VEGF and Anti-PD-1 Therapy in Combination of Gut Microbiota Transplantation: A Case Report
por: Cheng, Xianshuo, et al.
Publicado: (2023)

Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade
por: Liu, Xiaoliang, et al.
Publicado: (2019)

A Case of Complete Remission in Proficient Mismatch Repair (pMMR) Advanced Colon Cancer Treated with Sintilimab and XELOX
por: Zhu, Jiangpeng, et al.
Publicado: (2023)

Different surgical outcome and follow-up status between dMMR and pMMR colorectal cancer patients who fulfilled with Amsterdam-II criteria
por: Sun, Ci-Yuan, et al.
Publicado: (2020)

Analysis of Immune Landscape Reveals Prognostic Significance of Cytotoxic CD4(+) T Cells in the Central Region of pMMR CRC
por: Qi, Jingwen, et al.
Publicado: (2021)

Gene Expression Profile Reveals a Prognostic Signature of Non–MSI-H/pMMR Colorectal Cancer
por: Liu, Zaoqu, et al.
Publicado: (2022)

MiR-6511b-5p suppresses metastasis of pMMR colorectal cancer through methylation of CD44 by directly targeting BRG1
por: Sun, JinMing, et al.
Publicado: (2022)

Fruquintinib in Combination With PD-1 Inhibitors in Patients With Refractory Non-MSI-H/pMMR Metastatic Colorectal Cancer: A Real-World Study in China
por: Gou, Miaomiao, et al.
Publicado: (2022)

Efficacy and safety of immune checkpoint inhibitors in Proficient Mismatch Repair (pMMR)/ Non-Microsatellite Instability-High (non-MSI-H) metastatic colorectal cancer: a study based on 39 cohorts incorporating 1723 patients
por: Wu, Qing, et al.
Publicado: (2023)

Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer that are non-microsatellite instability high (non-MSI-high) or mismatch repair proficient (pMMR) in the United States
por: Kelkar, Sneha S., et al.
Publicado: (2022)

APC(+/−) alters colonic fibroblast proteome in FAP
por: Patel, Bhavinkumar B., et al.
Publicado: (2011)

Gaelic Medical Mss. and Their Authors
por: Mackinnon, Donald
Publicado: (1895)

Gaelic Medical Mss. and Their Authors
por: Mackinnon, Donald
Publicado: (1895)

Abscopal effect triggered by radiation sequential mono-immunotherapy resulted in a complete remission of PMMR sigmoid colon cancer
por: Zhou, Pu, et al.
Publicado: (2023)

Clinical Application of Adaptive Immune Therapy in MSS Colorectal Cancer Patients
por: Wang, Danyang, et al.
Publicado: (2021)

Chemically Induced Oncogenesis in the Peripheral Nervous System Is Suppressed in Congenic BDIX.BDIV-Mss1 and -Mss7 Rats
por: Koelsch, Bernd, et al.
Publicado: (2015)

KDM5c Promotes Colon Cancer Cell Proliferation Through the FBXW7-c-Jun Regulatory Axis
por: Lin, Haishan, et al.
Publicado: (2020)

Three English Medical MSS., 1550-1660
por: Young, John
Publicado: (1900)

Endometrial Tumors with MSI-H and dMMR Share a Similar Tumor Immune Microenvironment
por: Song, Yunfeng, et al.
Publicado: (2021)

The clinicopathological characteristics, prognosis and immune microenvironment mapping in MSI-H/MMR-D endometrial carcinomas
por: Guo, Yu-e, et al.
Publicado: (2022)

Mss116p: A DEAD-box protein facilitates RNA folding
por: Sachsenmaier, Nora, et al.
Publicado: (2013)

Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects
por: Suarez-Carmona, Meggy, et al.
Publicado: (2021)

Protein arginine methyltransferase 8 gene enhances the colon cancer stem cell (CSC) function by upregulating the pluripotency transcription factor
por: Lin, Haishan, et al.
Publicado: (2018)

The Unpublished MSS. of the Late Alfred Wigan, M.D.
Publicado: (1849)

Note on Some Medical Mss. and Books in the Hunterian Library
por: Ferguson, Mungo
Publicado: (1922)

oHSV2 Can Target Murine Colon Carcinoma by Altering the Immune Status of the Tumor Microenvironment and Inducing Antitumor Immunity
por: Zhang, Wen, et al.
Publicado: (2020)

Endometrial cancer risk and survival by tumor MMR status
por: Nagle, Christina M., et al.
Publicado: (2018)

Combined Treatment with Immunotherapy-Based Strategies for MSS Metastatic Colorectal Cancer
por: Baraibar, Iosune, et al.
Publicado: (2021)

Mss4 protein is a regulator of stress response and apoptosis
por: Walter, B M, et al.
Publicado: (2012)

The Marker State Space (MSS) Method for Classifying Clinical Samples
por: Fallon, Brian P., et al.
Publicado: (2013)

Some Later Medieval Latin Medical MSS at Bern and Prag
por: Thorndike, Lynn
Publicado: (1936)

Structural basis for RNA duplex recognition and unwinding by the DEAD-box helicase Mss116p
por: Mallam, Anna L., et al.
Publicado: (2012)

Treatment with the PARP inhibitor, niraparib, sensitizes colorectal cancer cell lines to irinotecan regardless of MSI/MSS status
por: Genther Williams, Sybil M, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7css9a82aftc0f318eumfctnqn